Granting stock options to directors, executive officers and subsidiary officers
First written in FY2017-Q2. 7 of 9 entries say "Advanced", first in FY2017. Latest entry: FY2021.
Biprogy moved to the "Worse" side of this theme in 2021, 3 years before the typical company in this theme (2024).
The whole theme swung hardest in 2021: 5 of 36 companies on the "Worse" side.
4 other companies' latest entry also says "Reframed".
- FY2021ReframedAnnual report
「From the following consolidated fiscal year onward, compensation for executive directors will comprise (a) fixed compensation (monthly compensation), (b) bonuses linked to short-term performance, and (c) restricted stock compensation linked to medium- to long-term performance and other factors. The ratio of a):b):c) will be 4:4:2.」
The company presented a compensation structure under which medium- to long-term compensation will shift from being centered on stock options to restricted stock compensation from the following fiscal year onward. - FY2021-Q2AdvancedAnnual report
「The terms of the share acquisition rights issued as stock options during the second quarter accounting period were as follows.」
Under the resolution dated 25 June 2020, share acquisition rights comprising 376 units and covering 37,600 shares were issued to 20 directors and executive officers of the company and its subsidiaries. - FY2020AdvancedAnnual report
「The 2019 stock options relate to rights that lapsed based on the performance achievement rate.」
The company disclosed that, of the 39,400 shares underlying the 2019 stock options, rights covering 16,800 shares lapsed based on the performance achievement rate, leaving 22,600 shares remaining unexercised. - FY2019AdvancedAnnual report
「The 2018 stock options relate to rights that lapsed based on the performance achievement rate.」
Rights covering 22,600 shares under the 2018 stock options lapsed based on the performance achievement rate, leaving 33,400 shares remaining unexercised. A resolution was also passed to grant share acquisition rights covering up to 78,900 shares under the resolution dated 26 June 2019. - FY2019-Q2AdvancedAnnual report
「The terms of the share acquisition rights issued as stock options during the second quarter accounting period were as follows.」
Under the resolution passed on 27 June 2018, share acquisition rights comprising 560 units and covering 56,000 shares were issued to 24 directors and executive officers of the company and its subsidiaries. The exercise period runs from 1 July 2019 through 30 June 2049. - FY2018AdvancedAnnual report
「The 2017 stock options relate to rights that lapsed based on the performance achievement rate.」
Of the 94,000 shares underlying the 2017 stock options, rights covering 44,700 shares lapsed based on the performance achievement rate, leaving 49,300 shares remaining unexercised. - FY2018-Q2AdvancedAnnual report
「The share acquisition rights and other instruments issued during the second quarter accounting period were as follows.」
The disclosure describes the issuance of share acquisition rights approved on 28 June 2017, covering 67,200 shares for the company's directors and executive officers and 26,800 shares for directors and executive officers of subsidiaries. - FY2017AdvancedAnnual report
「The 2016 stock options relate to rights that lapsed based on the performance achievement rate.」
Of the 168,000 shares underlying the 2016 stock options, rights covering 83,000 shares lapsed based on the performance achievement rate, leaving 85,000 shares remaining unexercised. On 28 June 2017, a resolution was also passed to grant new rights covering up to 157,800 shares. - FY2017-Q2First statedAnnual report
「The share acquisition rights and other instruments issued during the second quarter accounting period were as follows.」
Share acquisition rights covering a total of 168,000 shares were granted to directors and executive officers of the company and its subsidiaries. The performance evaluation period runs through 31 March 2017, and the exercise period runs from 1 July 2017 through 30 June 2047.